Advanced Biomed Inc. Completes Successful IPO Launch
TipRanks (Mon, 10-Mar 4:55 PM ET)
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
Globe Newswire (Fri, 7-Mar 12:29 PM ET)
Advanced Biomed prices IPO at $4 per share
Seeking Alpha News (Thu, 6-Mar 9:12 AM ET)
Advanced Biomed Inc. Announces Pricing of Initial Public Offering
Globe Newswire (Thu, 6-Mar 9:02 AM ET)
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Advanced Biomed trades on the NASDAQ stock market under the symbol ADVB.
As of March 10, 2025, ADVB stock price declined to $3.51 with 133,746 million shares trading.
ADVB has a market cap of $76.05 million. This is considered a Micro Cap stock.
ADVB support price is $3.36 and resistance is $3.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADVB shares will trade within this expected range on the day.